Linda Cherry
President
Linda Cherry is President of Zahav Bioscience, where she leads the company’s strategic vision, operations, and long-term growth initiatives. She brings more than 30 years of experience across oncology development, regulatory affairs, portfolio strategy, commercialization, business development and operations —from start-ups and growth-stage companies to mature, global organizations.
A cancer survivor, Linda is deeply committed to improving patient outcomes and brings a people-centered approach to leadership and decision-making. She has a proven track record of building and scaling high-performing teams and organizations, shaping corporate and portfolio strategy, launching and optimizing commercial products, ensuring operational excellence and transacting deals in challenging market environments. She is recognized for driving innovation, disciplined execution, and value creation.
Prior to joining Zahav Bioscience, Linda held executive roles at Syneos Health, Ipsen Biopharmaceuticals, and Radius Health. Earlier in her career, she held a range of technical, commercial and operational roles at Johnson & Johnson, Gilead Sciences and Merck.
Linda holds a BA from the University of Pennsylvania.